<DOC>
	<DOCNO>NCT00350480</DOCNO>
	<brief_summary>To determine relative efficacy multidose medroxyprogesterone acetate ( MPA , Provera ) multidose , monophasic combination oral contraceptive treatment hemodynamically stable woman non-gestational , acute uterine bleeding .</brief_summary>
	<brief_title>Treatment Non-Gestational Acute Uterine Bleeding : A Randomized Trial</brief_title>
	<detailed_description>Acute uterine bleeding , unrelated pregnancy , relatively common problem cause many reproductive-aged woman requite emergent medical and/or surgical intervention . Although traditional approach generally surgical nature , many practitioner utilize medical method arrest bleed . However , despite widespread use , exist paucity information regard effectiveness , side-effects , patient satisfaction associate commonly-used medical regimen . ( b ) The purpose study compare efficacy multidose medroxyprogesterone acetate multidose , monophasic combine oral contraceptive treatment hemodvnamically-stable woman non-gestational , acute uterine bleeding . ( c ) Non-pregnant , hemodynamically-stable , reproductive-aged , woman , age IS , present either emergency area KP practitioner 's office acute uterine bleeding , consider eligibility . If , follow full exam medically appropriate investigation medical management deem appropriate , approached member investigate team possible inclusion study . Following informed consent , patient randomize receive either medroxyprogesterone acetate ( 20 mg three time daily 7 day ) monophasic oral contraceptive contain I mg norethindrone 35 ug ethinyl estradiol ( three dines daily seven day ) . Following seven day therapy , randomize MPA continue 20 mg per day three week randomize oral contraceptive take one pill per day three week , complete total four week therapy . The primary outcome number day cessation bleeding . Other outcome measure include pad tampon count , hemoglobin level . Chi square test student use evaluate difference two treatment group . The hope study elucidate efficacy two regimen .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Nonpregnant Hemodynamically stable Reproductiveaged woman &gt; 18 year Present acute uterine bleeding Pregnant Nonhemodynamically stable &lt; 18 year</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>acute uterine bleeding</keyword>
</DOC>